Company / Book Value per Share
Relay Therapeutics, Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.38
FY2025
5-year range
-$2.007 / $7.054
FY2021-FY2025
Trend
-44.6%
vs FY2024
Sector context
#127 of 209
Health Care
What the data says
At $3.38, Relay Therapeutics, Inc.'s book value per share ranks #127 of 209 in the Health Care sector. Book Value per Share has declined for 3 consecutive years, from $7.054 in FY2022 to $3.38 in FY2025.
Based on SEC 10-K filings.
$3.38 in FY2025 with a 3-year CAGR of -21.7%.
Declined from $6.209 to $3.38 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -21.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#127 of 209 in Health CareTop 61% of 209This company $3.38 Sector average $215.686
▼
-98.4% below sector average
Key checks
Key Insights
- Relay Therapeutics, Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -21.7%, indicating a declining trend.
- In FY2025, book value per share decreased 44.6% year-over-year.
- Ranks #127 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.38 | -44.6% |
| FY2024 | $6.102 | -1.7% |
| FY2023 | $6.209 | -12.0% |
| FY2022 | $7.054 | +451.5% |
| FY2021 | -$2.007 | +92.7% |
| FY2020 | -$27.474 | +47.5% |
| FY2019 | -$52.293 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026